Results 161 to 170 of about 16,162 (223)

Investigation of the expression level of human endogenous retrovirus E env transcript in cervical cancer. [PDF]

Retrovirology
Jahanshahi S, Soleimani-Jelodar R, Jalilvand S, Shoja Z, Farahmand M, Arashkia A, Marashi SM.   +6 more
europepmc   +1 more source

High-risk HPV E6 induces an aneuploidy-prone chromosome congression defect through destabilization of CENP-E. [PDF]

J Virol
Seshimo N, Hori K, Furuta R, Hirota T, Nozawa R-S.   +4 more
europepmc   +1 more source

The Exploration of Therapeutic Antivirals for Human Papillomavirus in the Last 40 Years: Bibliometric Research. [PDF]

Pathogens
Jiang Z, Jin L, Wu C, Li Z, Lou Z, Qu P.
europepmc   +1 more source

Innate immune recognition and microenvironmental reprogramming in HPV-induced cervical cancer: from pattern recognition receptor activation to immune tolerance disruption. [PDF]

Front Cell Infect Microbiol
Khan SU, Halawi MH, Almehmadi M, Taha R, Ahmed AE, Alfaifi MY, Shati AA, Elbehairi SEI, Ahmad S, Alanazi YF, Al-Rasheed M, Pandupuspitasari NS, Widiastuti E, Khan MU.   +13 more
europepmc   +1 more source

Prevalence of vaginal microecological disorder and its association with HPV infections in pregnant women attending prenatal examinations. [PDF]

Microbiol Spectr
Shen J, Wang L, Lin W, Wang D, Wang L, Chen J, Sun P.   +6 more
europepmc   +1 more source

Systems Vaccinology-Integrated Proteomics to Develop a Novel Prophylactic and Therapeutic Vaccine Against Human Papillomavirus 16. [PDF]

Bioinform Biol Insights
Fathi S, Solhjoo A, Bagheri A, Sakhteman A, Ghasemi Y, Negahdaripour M.   +5 more
europepmc   +1 more source

Cervical human papillomavirus: the therapeutic target of botanical drugs. [PDF]

Front Pharmacol
Tang YC, Zhang EF, Zhong HZ, Li MY, Wei SB.   +4 more
europepmc   +1 more source

p53 Positivity Predicts Poor Survival in Oropharyngeal Squamous Cell Carcinoma Dependent on HPV Status. [PDF]

Cancers (Basel)
de Oliveira LQR, Farshadi F, Mlynarek A, Mascarella MA, Hier M, Coletta RD, Wurzba SDS.   +6 more
europepmc   +1 more source

A prospective observational study on the value of HPV E6/E7 oncoprotein immunocytochemistry for triaging HPV-positive women. [PDF]

Front Med (Lausanne)
Pan Z, Sun Q, Wang Y, Zhang J, Zhang Y, Miao J.   +5 more
europepmc   +1 more source

Structurally-optimised HPV16 E7/E6 mRNA-LPP mediates dose-sparing efficacy via tumour microenvironment reprogramming. [PDF]

Mol Biomed
Sun S, Deng Y, Ren J, Han X, Bing J, Wang T, Hao Z, Tian H, Zhang L, Tan W.   +9 more
europepmc   +1 more source